Non-Current Liabilities
Operating Lease Liability Payments - 2028 (Lessee)
Neurocrine Biosciences Operating Lease Liability Payments - 2028 (Lessee) increased by 0.5% to $60.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $60.80M to $60.70M.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ2 2020
Last reportedQ1 2026May 5, 2026
Metric ID:
lease_liability_payments_2028_lesseeHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.50M | $15.50M | $15.70M | $15.70M | $15.70M | $16.00M | $16.00M | $16.00M | $35.60M | $36.60M | $36.60M | $60.80M | $60.80M | $60.40M | $60.70M |
| QoQ Change | — | +0.0% | +1.3% | +0.0% | +0.0% | +1.9% | +0.0% | +0.0% | +122.5% | +2.8% | +0.0% | +66.1% | +0.0% | -0.7% | +0.5% |
| YoY Change | — | — | — | +1.3% | +1.3% | +1.9% | +1.9% | +1.9% | +122.5% | +128.8% | +128.8% | +70.8% | +66.1% | +65.0% | -0.2% |
Range$15.50M – $60.80M
CAGR+47.7%
Avg YoY Growth+49.2%
Median YoY Growth+33.5%
Operating Lease Liability Payments - 2028 (Lessee) at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's operating lease liability payments - 2028 (lessee)?
- Neurocrine Biosciences (NBIX) reported operating lease liability payments - 2028 (lessee) of $60.70M in Q1 2026.
- How has Neurocrine Biosciences's operating lease liability payments - 2028 (lessee) changed year-over-year?
- Neurocrine Biosciences's operating lease liability payments - 2028 (lessee) decreased by 0.2% year-over-year, from $60.80M to $60.70M.